| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
From the Department of Pathology,*
College of Physicians
and Surgeons, Columbia University, New York, New York; the
Department of Pathology,
Lugio
Sacco Hospital, Milan, Italy; the Department of Microbiology, Molecular
Genetics and Immunology,
The University of
Kansas Medical Center, Kansas City, Kansas; the Institute of Infectious
Disease and Tropical Medicine,§
University of
Milan, Luigi Sacco Hospital, Milan, Italy; the Department of
Pathology,¶
IRCCS Ospedale San Matteo, University
of Pavia, Pravia, Italy; and the Division of
Epidemiology,||
Columbia University, New York,
New York
Kaposi’s sarcoma (KS)-associated herpesvirus (KSHV) is linked to KS, primary effusion lymphomas (PEL), and a subset of multicentric Castleman’s disease (MCD). Transcript mapping studies using PEL cell lines have allowed preliminary classification of viral gene expression into constitutive (class I) and inducible (class II/III) categories. To determine whether viral gene expression differs in vivo, we examined tissue sections of KSHV-infected disorders, using specific antibodies against proteins that are representative of the different expression classes of KSHV genes. ORF73/LANA appears to be a surrogate marker for KSHV infection because it is constitutively expressed in vitro and in vivo in all KSHV-infected cells. Expression of vIRF1, vIL6, and PF-8 proteins in the infected B cells of MCD lymph nodes reproduces the expression pattern observed in TPA-stimulated KSHV-infected B-cell lines. In contrast, the protein expression of the inducible viral genes that we tested in KS and PEL biopsies is restricted to PF-8 and vIL6, respectively. The tightly restricted expression of KSHV proteins in vivo differs from the dysregulated expression of inducible KSHV genes in vitro and suggests that viral gene expression in KSHV-infected cell lines does not accurately reflect what occurs in diseased tissues. These differences may be related to either cell-specific or immune restriction of viral replication.
This article has been cited by other articles:
 |
|
 |
|
  R. Rozen, N. Sathish, Y. Li, and Y. Yuan Virion-Wide Protein Interactions of Kaposi's Sarcoma-Associated Herpesvirus J. Virol., May 15, 2008; 82(10): 4742 - 4750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rappocciolo, H. R. Hensler, M. Jais, T. A. Reinhart, A. Pegu, F. J. Jenkins, and C. R. Rinaldo Human Herpesvirus 8 Infects and Replicates in Primary Cultures of Activated B Lymphocytes through DC-SIGN J. Virol., May 15, 2008; 82(10): 4793 - 4806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sander, A. Konrad, M. Thurau, E. Wies, R. Leubert, E. Kremmer, H. Dinkel, T. Schulz, F. Neipel, and M. Sturzl Intracellular Localization Map of Human Herpesvirus 8 Proteins J. Virol., February 15, 2008; 82(4): 1908 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Guihot, E. Oksenhendler, L. Galicier, A.-G. Marcelin, L. Papagno, A.-S. Bedin, F. Agbalika, N. Dupin, J. Cadranel, B. Autran, et al. Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells Blood, February 1, 2008; 111(3): 1387 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bower, T. Powles, S. Williams, T. N. Davis, M. Atkins, S. Montoto, C. Orkin, A. Webb, M. Fisher, M. Nelson, et al. Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease Ann Intern Med, December 18, 2007; 147(12): 836 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M-Q Du, C M Bacon, and P G Isaacson Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders J. Clin. Pathol., December 1, 2007; 60(12): 1350 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, H. J. Martin, G. Liao, and S. D. Hayward The Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Stabilizes and Activates c-Myc J. Virol., October 1, 2007; 81(19): 10451 - 10459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Nun, D. J. Kroll, N. H. Oberlies, D. D. Soejarto, R. J. Case, P. Piskaut, T. Matainaho, C. Hilscher, L. Wang, D. P. Dittmer, et al. Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus Mol. Cancer Ther., August 1, 2007; 6(8): 2360 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Davis, K. E. Singer, I. P. Reynolds, M. Haque, and R. Yarchoan Hypoxia Enhances the Phosphorylation and Cytotoxicity of Ganciclovir and Zidovudine in Kaposi's Sarcoma-Associated Herpesvirus Infected Cells Cancer Res., July 15, 2007; 67(14): 7003 - 7010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, M. M. Brinkmann, M. Pietrek, M. Ottinger, O. Dittrich-Breiholz, M. Kracht, and T. F. Schulz Functional characterization of the M-type K15-encoded membrane protein of Kaposi's sarcoma-associated herpesvirus J. Gen. Virol., June 1, 2007; 88(6): 1698 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Adang, C. Tomescu, W. K. Law, and D. H. Kedes Intracellular Kaposi's Sarcoma-Associated Herpesvirus Load Determines Early Loss of Immune Synapse Components J. Virol., May 15, 2007; 81(10): 5079 - 5090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, H. Martin, M. Shamay, C. Woodard, Q.-Q. Tang, and S. D. Hayward Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Downregulates Nuclear Glycogen Synthase Kinase 3 Activity and Consequently Blocks Differentiation J. Virol., May 1, 2007; 81(9): 4722 - 4731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Petre, S.-H. Sin, and D. P. Dittmer Functional p53 Signaling in Kaposi's Sarcoma-Associated Herpesvirus Lymphomas: Implications for Therapy J. Virol., February 15, 2007; 81(4): 1912 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xu and D. Ganem Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells J. Gen. Virol., January 1, 2007; 88(1): 46 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Brinkmann, M. Pietrek, O. Dittrich-Breiholz, M. Kracht, and T. F. Schulz Modulation of Host Gene Expression by the K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus J. Virol., January 1, 2007; 81(1): 42 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ottinger, T. Christalla, K. Nathan, M. M. Brinkmann, A. Viejo-Borbolla, and T. F. Schulz Kaposi's Sarcoma-Associated Herpesvirus LANA-1 Interacts with the Short Variant of BRD4 and Releases Cells from a BRD4- and BRD2/RING3-Induced G1 Cell Cycle Arrest J. Virol., November 1, 2006; 80(21): 10772 - 10786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chen and J. Nicholas Structural Requirements for gp80 Independence of Human Herpesvirus 8 Interleukin-6 (vIL-6) and Evidence for gp80 Stabilization of gp130 Signaling Complexes Induced by vIL-6 J. Virol., October 1, 2006; 80(19): 9811 - 9821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Adang, C. H. Parsons, and D. H. Kedes Asynchronous Progression through the Lytic Cascade and Variations in Intracellular Viral Loads Revealed by High-Throughput Single-Cell Analysis of Kaposi's Sarcoma-Associated Herpesvirus Infection. J. Virol., October 1, 2006; 80(20): 10073 - 10082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shamay, A. Krithivas, J. Zhang, and S. D. Hayward Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA PNAS, September 26, 2006; 103(39): 14554 - 14559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn Kaposi's sarcoma-associated herpesvirus immune modulation: an overview J. Gen. Virol., July 1, 2006; 87(7): 1781 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Verma, T. Choudhuri, R. Kaul, and E. S. Robertson Latency-Associated Nuclear Antigen (LANA) of Kaposi's Sarcoma-Associated Herpesvirus Interacts with Origin Recognition Complexes at the LANA Binding Sequence within the Terminal Repeats J. Virol., March 1, 2006; 80(5): 2243 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Viejo-Borbolla, M. Ottinger, E. Bruning, A. Burger, R. Konig, E. Kati, J. A. Sheldon, and T. F. Schulz Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1 J. Virol., November 1, 2005; 79(21): 13618 - 13629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Wheat, C. D. Cool, Y. Morimoto, P. R. Rai, C. H. Kirkpatrick, B. A. Lindenbaum, C. A. Bates, M. C. Ellison, A. E. Serls, K. K. Brown, et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency J. Exp. Med., August 15, 2005; 202(4): 479 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Seo, J. Park, and J. Choe Kaposi's Sarcoma-Associated Herpesvirus Viral IFN Regulatory Factor 1 Inhibits Transforming Growth Factor-{beta} Signaling Cancer Res., March 1, 2005; 65(5): 1738 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lu, Y. Zeng, Z. Huang, L. Huang, C. Qian, G. Tang, and D. Qin Human Herpesvirus 6 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus Am. J. Pathol., January 1, 2005; 166(1): 173 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Meads and P. G. Medveczky Kaposi's Sarcoma-associated Herpesvirus-encoded Viral Interleukin-6 Is Secreted and Modified Differently Than Human Interleukin-6: EVIDENCE FOR A UNIQUE AUTOCRINE SIGNALING MECHANISM J. Biol. Chem., December 10, 2004; 279(50): 51793 - 51803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. Krug, V. P. Pozharskaya, Y. Yu, N. Inoue, and M. K. Offermann Inhibition of Infection and Replication of Human Herpesvirus 8 in Microvascular Endothelial Cells by Alpha Interferon and Phosphonoformic Acid J. Virol., August 1, 2004; 78(15): 8359 - 8371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Berezne, F. Agbalika, E. Oksenhendler, C. Casper, W. G. Nichols, M.-L. Huang, L. Corey, and A. Wald Failure of cidofovir in HIV-associated multicentric Castleman disease Blood, June 1, 2004; 103(11): 4368 - 4369. [Full Text] [PDF]
|
|
|
|
|
|
J. H. Jeong, J. Orvis, J. W. Kim, C. P. McMurtrey, R. Renne, and D. P. Dittmer Regulation and Autoregulation of the Promoter for the Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus J. Biol. Chem., April 16, 2004; 279(16): 16822 - 16831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Milligan, M. Robinson, E. O'Donnell, and D. J. Blackbourn Inflammatory Cytokines Inhibit Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Transcription in In Vitro-Infected Endothelial Cells J. Virol., March 1, 2004; 78(5): 2591 - 2596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. McClain, Y. Natkunam, and S. H. Swerdlow Atypical Cellular Disorders Hematology, January 1, 2004; 2004(1): 283 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. O'Connor, B. Damania, and D. H. Kedes De Novo Infection with Rhesus Monkey Rhadinovirus Leads to the Accumulation of Multiple Intranuclear Capsid Species during Lytic Replication but Favors the Release of Genome-Containing Virions J. Virol., December 15, 2003; 77(24): 13439 - 13447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Brinkmann, M. Glenn, L. Rainbow, A. Kieser, C. Henke-Gendo, and T. F. Schulz Activation of Mitogen-Activated Protein Kinase and NF-{kappa}B Pathways by a Kaposi's Sarcoma-Associated Herpesvirus K15 Membrane Protein J. Virol., September 1, 2003; 77(17): 9346 - 9358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tomescu, W. K. Law, and D. H. Kedes Surface Downregulation of Major Histocompatibility Complex Class I, PE-CAM, and ICAM-1 following De Novo Infection of Endothelial Cells with Kaposi's Sarcoma-Associated Herpesvirus J. Virol., September 1, 2003; 77(17): 9669 - 9684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujimuro and S. D. Hayward The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Manipulates the Activity of Glycogen Synthase Kinase-3{beta} J. Virol., July 15, 2003; 77(14): 8019 - 8030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-S. Lee, M. Connole, Z. Tang, N. L. Harris, and J. U. Jung Structural Analysis of the Kaposi's Sarcoma-Associated Herpesvirus K1 Protein J. Virol., July 15, 2003; 77(14): 8072 - 8086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Watanabe, M. Sugaya, A. M. Atkins, E. A. Aquilino, A. Yang, D. L. Borris, J. Brady, and A. Blauvelt Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells J. Virol., June 1, 2003; 77(11): 6188 - 6196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-Z. Wang, S. M. Akula, N. Sharma-Walia, L. Zeng, and B. Chandran Human Herpesvirus 8 Envelope Glycoprotein B Mediates Cell Adhesion via Its RGD Sequence J. Virol., March 1, 2003; 77(5): 3131 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Q. Du, T. C. Diss, H. Liu, H. Ye, R. A. Hamoudi, J. Cabecadas, H. Y. Dong, N. L. Harris, J. K. C. Chan, J. W. Rees, et al. KSHV- and EBV-associated germinotropic lymphoproliferative disorder Blood, October 16, 2002; 100(9): 3415 - 3418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Deng, J. T. Chu, M. B. Rettig, O. Martinez-Maza, and R. Sun Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression Blood, August 13, 2002; 100(5): 1919 - 1921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Deng, M. J. Song, J. T. Chu, and R. Sun Transcriptional Regulation of the Interleukin-6 Gene of Human Herpesvirus 8 (Kaposi's Sarcoma-Associated Herpesvirus) J. Virol., July 17, 2002; 76(16): 8252 - 8264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Coulter and H. W. Reid Isolation and expression of three open reading frames from ovine herpesvirus-2 J. Gen. Virol., March 1, 2002; 83(3): 533 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Widmer, M. Wernli, F. Bachmann, F. Gudat, G. Cathomas, and P. Erb Differential Expression of Viral Bcl-2 Encoded by Kaposi's Sarcoma-Associated Herpesvirus and Human Bcl-2 in Primary Effusion Lymphoma Cells and Kaposi's Sarcoma Lesions J. Virol., March 1, 2002; 76(5): 2551 - 2556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. V. Sharp, H.-W. Wang, A. Koumi, D. Hollyman, Y. Endo, H. Ye, M.-Q. Du, and C. Boshoff K15 Protein of Kaposi's Sarcoma-Associated Herpesvirus Is Latently Expressed and Binds to HAX-1, a Protein with Antiapoptotic Function J. Virol., January 15, 2002; 76(2): 802 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Corbellino, G. Bestetti, C. Scalamogna, S. Calattini, M. Galazzi, L. Meroni, D. Manganaro, M. Fasan, M. Moroni, M. Galli, et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy Blood, December 1, 2001; 98(12): 3473 - 3475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Liu, Y. Okruzhnov, H. Li, and J. Nicholas Human Herpesvirus 8 (HHV-8)-Encoded Cytokines Induce Expression of and Autocrine Signaling by Vascular Endothelial Growth Factor (VEGF) in HHV-8-Infected Primary-Effusion Lymphoma Cell Lines and Mediate VEGF-Independent Antiapoptotic Effects J. Virol., November 15, 2001; 75(22): 10933 - 10940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Groves, M. A. Cotter, C. Subramanian, and E. S. Robertson The Latency-Associated Nuclear Antigen Encoded by Kaposi's Sarcoma-Associated Herpesvirus Activates Two Major Essential Epstein-Barr Virus Latent Promoters J. Virol., October 1, 2001; 75(19): 9446 - 9457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Caussinus, F Meggetto, G Delsol, and P Brousset Simultaneous occurrence of Epstein-Barr virus associated Hodgkin's disease and HHV-8 related multicentric Castleman's disease: a fortuitous event? J. Clin. Pathol., October 1, 2001; 54(10): 790 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sakurada, H. Katano, T. Sata, H. Ohkuni, T. Watanabe, and S. Mori Effective Human Herpesvirus 8 Infection of Human Umbilical Vein Endothelial Cells by Cell-Mediated Transmission J. Virol., August 15, 2001; 75(16): 7717 - 7722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rimessi, A. Bonaccorsi, M. Sturzl, M. Fabris, E. Brocca-Cofano, A. Caputo, G. Melucci-Vigo, M. Falchi, A. Cafaro, E. Cassai, et al. Transcription Pattern of Human Herpesvirus 8 Open Reading Frame K3 in Primary Effusion Lymphoma and Kaposi's Sarcoma J. Virol., August 1, 2001; 75(15): 7161 - 7174. [Abstract] [Full Text]
|
|
|
|
|
|
T. Seo, J. Park, D. Lee, S. G. Hwang, and J. Choe Viral Interferon Regulatory Factor 1 of Kaposi's Sarcoma-Associated Herpesvirus Binds to p53 and Represses p53-Dependent Transcription and Apoptosis J. Virol., July 1, 2001; 75(13): 6193 - 6198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Haque, K. Ueda, K. Nakano, Y. Hirata, C. Parravicini, M. Corbellino, and K. Yamanishi Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 J. Gen. Virol., May 1, 2001; 82(5): 1175 - 1180. [Abstract] [Full Text]
|
|
|
|
|
|
H. Li, H. Wang, and J. Nicholas Detection of Direct Binding of Human Herpesvirus 8-Encoded Interleukin-6 (vIL-6) to both gp130 and IL-6 Receptor (IL-6R) and Identification of Amino Acid Residues of vIL-6 Important for IL-6R-Dependent and -Independent Signaling J. Virol., April 1, 2001; 75(7): 3325 - 3334. [Abstract] [Full Text]
|
|
|
|
|
|
M.-Q. Du, H. Liu, T. C. Diss, H. Ye, R. A. Hamoudi, N. Dupin, V. Meignin, E. Oksenhendler, C. Boshoff, and P. G. Isaacson Kaposi sarcoma-associated herpesvirus infects monotypic (IgM{lambda}) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders Blood, April 1, 2001; 97(7): 2130 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, K. Ueda, S. Sakakibara, T. Okuno, C. Parravicini, M. Corbellino, and K. Yamanishi Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator PNAS, March 27, 2001; 98(7): 4119 - 4124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rivas, A.-E. Thlick, C. Parravicini, P. S. Moore, and Y. Chang Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53 J. Virol., January 1, 2001; 75(1): 429 - 438. [Abstract] [Full Text]
|
|
|
|
|
|
A. Krithivas, D. B. Young, G. Liao, D. Greene, and S. D. Hayward Human Herpesvirus 8 LANA Interacts with Proteins of the mSin3 Corepressor Complex and Negatively Regulates Epstein-Barr Virus Gene Expression in Dually Infected PEL Cells J. Virol., October 15, 2000; 74(20): 9637 - 9645. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Washenik, L. Clark-Loeser, A. Friedman-Kien, T. Simonart, J.-P. V. Vooren, S. Meuris, A. Mazzone, E. Ottini, M. Paulli, K. Antman, et al. Kaposi's Sarcoma N. Engl. J. Med., August 24, 2000; 343(8): 581 - 584. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
